Toxic epidermal necrolysis and Stevens Johnson syndrome are potentially life-threatening drug reactions, which have been effectively treated with intravenous immunoglobulin.

Jennifer Trent, MD
Dr. Trent completed a six year combined BS-MD at the University of Miami with an undergraduate degree in biology and a minor in chemistry. While in medical school, she interrupted her formal course to participate in a two-year research fellowship under the direction of Robert Kirsner, MD. The focus of her work was hospital care of dermatology patients, toxic epidermal necrolysis and wound care. Dr. Trent graduated from Medical School with research distinction and also received the University of Miami Department of Dermatology's medical student of the year award.

Dr. Trent has published over 40 articles in peer-reviewed journals and 6 book chapters in various dermatologic text books on surgery and wound care. She has been interviewed by the American Academy of Dermatology's Dialogues in Dermatology and recently published her first book on dermatologic therapy.